Although studies have found that the EGFR pathway plays an important role in the occurrence and development of BCa, EGFR inhibition combined with cisplatin can significantly inhibit tumor growth in nude mice, yet EGFRi has not shown effective effects on BCa patients who are resistant to cisplatin in clinical practice [64,65]. This evidence concerns the gene EGFR and neoplasm.